Why MRI should come before biopsy
When a soft-tissue sarcoma is suspected, the safest sequence is usually imaging first, then a planned biopsy, followed by definitive treatment.
Why this matters
MRI defines the lesion’s extent, its relationship to muscles, fascia, vessels and nerves, and the areas most likely to yield diagnostic tissue. This information helps the multidisciplinary team select a biopsy path that can later be removed with the tumour if surgery is required.

The correct sequence
An unplanned incision or removal can alter anatomical planes, contaminate tissue compartments and make subsequent surgery more complex. A core-needle biopsy is often used, but the technique and route depend on the tumour’s location and the planned definitive operation.
Key point: the biopsy is part of the treatment plan, not a separate preliminary procedure.
Related resources
The pathway starts before surgery
In sarcoma, biopsy is part of the future operation. In a specialized sarcoma treatment unit, biopsy trajectory is planned together with the definitive surgical approach.
GEIS 2018 reported 3-year overall survival of 82% in reference centers vs 70.4% in local hospitals. NETSARC 2019 found surgery in a reference center independently associated with better overall survival (HR 0.681). These are observational data, not randomized comparisons. GEIS · NETSARC.